Skip to main content

2 Result(s)

within Yin You** Remove this filter Medicine & Public Health Remove this filter Dermatology Remove this filter Pharmacology/Toxicology Remove this filter

and

  1. Article

    Open Access

    Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 Studies

    Health-related quality of life (HRQoL) may be markedly impaired in patients with moderate-to-severe psoriasis.

    April W. Armstrong, Kristian Reich, Peter Foley… in American Journal of Clinical Dermatology (2019)

    Download PDF (877 KB) View Article

  2. No Access

    Article

    Maintenance of Response Through up to 4 Years of Continuous Guselkumab Treatment of Psoriasis in the VOYAGE 2 Phase 3 Study

    Guselkumab effectively treats moderate-to-severe psoriasis.

    Kristian Reich, April W. Armstrong, Peter Foley… in American Journal of Clinical Dermatology (2020)